Table 3.
Predictor of massive transfusion |
Area under curve (95% CI) |
Youden index |
Sensitivity, % |
Specificity, % |
Positive predictive value, % |
Negative predictive value, % |
---|---|---|---|---|---|---|
Lt-LY30 | 0.86 (0.79–0.93) | 27% | 84 | 82 | 50 | 96 |
Lt-TMA | 0.79 (0.71–0.87) | 23 min | 67 | 85 | 45 | 92 |
Ht-LY30 | 0.84 (0.77–0.91) | 71% | 80 | 84 | 50 | 95 |
Ht-TMA | 0.78 (0.71 – 8.5) | 16 min | 84 | 70 | 36 | 94 |
R-MA | 0.79 (0.73–0.85) | 57mm | 68 | 79 | 41 | 92 |
INR | 0.86 (0.81–0.91) | 1.1 | 90 | 69 | 33 | 97 |
Peltan (11)* | 1.5 | 42 | 95 | 58 | 88 | |
TASH | 0.84 (0.79–0.90) | 8 | 87 | 76 | 38 | 97 |
Brockamp (5)* | 8.5 | 86 | 74 | 44 | 96 | |
Shock index | 0.70 (0.61–0.80) | 1.07 | 63 | 77 | 37 | 92 |
Pottecher (39)* | 0.96 | 68 | 67 | 31 | 92 | |
ABC | 0.66 (0.58–0.74) | 1 | 85 | 37 | 22 | 92 |
Nunez (20)* | 2 | 38 | 82 | 30 | 87 |
Represent threshold recommend by prior researchers as thresholds for massive transfusion.
ABC, assessment of blood consumption score; Ht, high dose tissue plasminogen activator thrombelastography; INR, internal normalized ratio; Lt, low dose tissue plasminogen activator thrombelastography; LY30, percent clot lysis 30 minutes after reaching maximum amplitude; MA, maximum amplitude; R, rapid thrombelastography; TASH, trauma associated severe hemorrhage; TMA, time to maximum amplitude.